FAST NEWS: AIM Vaccine’s loss balloons
The latest: Vaccine maker AIM Vaccine Co. Ltd. (6660.HK) said on Monday it expects to report a net loss of 1.25 billion yuan ($174 million) to 1.38 billion yuan for last…
FAST NEWS: AIM Vaccine named to MSCI small cap index
The latest: AIM Vaccine Co. Ltd. (6660.HK), China’s second-largest maker of non-Covid vaccines, announced Friday that its shares were selected for inclusion in the MSCI Global Small Cap Index, effective after…
FAST NEWS: CanSino Spends $21 Million on Share Buyback
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) said Friday it bought back about 670,000 of its Shanghai-listed A-shares for 147 million yuan ($20.8 million) as of Nov. 30, accounting for…
Losses Mount at InnoCare but Cash Cushion Dulls the Pain
The cancer drug developer logged another loss in the latest quarter but a cash pile of more than 9.2 billion yuan can sustain its business for the next five yearsKey…
FAST NEWS: AIM Vaccine Surges 38% on Second Trading Day
The latest: Shares of AIM Vaccine Co. Ltd. (6660.HK), China’s second-largest maker of non-Covid vaccines, surged on their second trading day Friday after a modest 3.1% gain the previous day…
FAST NEWS: BeiGene’s Lymphoma Drug Recommended to Enter European Regulator
The latest: BeiGene Ltd. (BGNE.US; 6160.HK; 668235.SH) announced Monday that its Zanubrutinib drug has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European…
InnoCare Revs Up for Next Phase With Strong Results, IPO Plan
Sales of the company’s key Orelabrutinib cancer drug doubled in the first half of the year, contributing to a 142% revenue jump for the period Key Takeaways: InnoCare Pharma’s revenue…